Age-Related Macular Degeneration (ARMD) Clinical Trials

Find Age-Related Macular Degeneration (ARMD) Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Diabetes mellitus is a disorder of sugar and fat metabolism which results in damage to the small blood vessels in various organs, this includes the retina - the part of the eye that processes light into a nerve impulse. This leads to damage and blindness via various different mechanisms that are not fully understood. In this study the objective is to recruit people with diabetes and various stages of diabetic eye disease and measure a large number of different chemicals within the blood that might be associated with damage and dysfunction within the retina. Additionally, it will examine the different bacteria within the gut that might affect disease in the eye via chemicals circulating in the blood. This will require participants to have blood samples taken and to provide urine samples. The blood will be analysed with specialised instruments to identify specific molecules circulating within the blood. Participants will also need to allow researchers to look at their medical records, previous photographs and specialist scans of the back of the eye to grade their diabetic retinopathy. This will allow us to identify potential ways in which these could be targeted for future benefit for people with diabetes to hopefully prevent deterioration of their vision.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Diagnosis of type 2 diabetes mellitus

• Male or female aged 18 - 80 inclusive

Locations
Other Locations
United Kingdom
Prince Philip Hospital
RECRUITING
Llanelli
Contact Information
Primary
Francis WB Sanders, MB BChir PhD FRCOphth
francis.sanders@wales.nhs.uk
+447717171199
Backup
Eirini Skiadaresi
eirini.skiadaresi@wales.nhs.uk
+447427120616
Time Frame
Start Date: 2025-03-31
Estimated Completion Date: 2030-01-01
Participants
Target number of participants: 120
Treatments
Group 1 - No diabetic retinopathy or maculopathy
Group 1 - Patients with type 2 DM but No diabetic retinopathy or maculopathy
Group 2 - Mild preproliferative DR
Group 2 - Patients with Type 2 diabetes and Mild preproliferative DR
Group 3 - Moderate Pre-proliferative DR
Group 3 - Patients with type 2 diabetes and Moderate Pre-proliferative DR
Group 4 - Severe pre-proliferative DR
Group 4 - Patients with type 2 diabetes and Severe pre-proliferative DR
Group 5 - Proliferative DR
Group 5 - Patients with type 2 diabetes and Proliferative DR
Group 6 - DMO with any degree of DR and no prior treatment
Group 6 - Patients with type 2 diabetes and DMO with any degree of DR and no prior treatment
Related Therapeutic Areas
Diabetic Retinopathy
Diabetic Macular Edema (DME)
Late-Onset Retinal Degeneration
Type 2 Diabetes (T2D)
Age-Related Macular Degeneration (ARMD)
Sponsors
Collaborators: University of Aberdeen
Leads: Hywel Dda Health Board

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

NEI Intramural Biorepository for Retinal Diseases

NEI Intramural Biorepository for Retinal Diseases

Enrollment Status: Recruiting
Publish Date: November 19, 2025

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls

Enrollment Status: Recruiting
Publish Date: December 15, 2025

A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

Who is this study for: Patients with Age-Related Macular Degeneration
Enrollment Status: Recruiting
Publish Date: December 01, 2025
Intervention Type: Drug
Study Drug: iPSC-Derived Retinal Pigment Epithelium/Poly Lactic-Co-Glycolic Acid Transplantation
Study Phase: Phase 1/Phase 2
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved